Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2012
12/05/2012CN102805826A Drug for reducing weight and beautifying facial appearance and preparation method thereof
12/05/2012CN102805818A Hypoglycemic drug and preparation method thereof
12/05/2012CN102805787A Health-care medicinal liquor
12/05/2012CN102805755A Preparation method of high-quality ginkgo flavone
12/05/2012CN102805744A Pharmaceutical composition for treating or preventing obesity and metabolic syndrome
12/05/2012CN102805743A Application of arctigenin in treating angiogenesis diseases
12/05/2012CN102805739A Fluvastatin sodium sustained-release coated dropping pills and preparation method thereof
12/05/2012CN102302673B Traditional Chinese medicine compound preparation for preventing and treating diabetic nephropathy (DN)
12/05/2012CN102258758B High-content liquid gingerols and preparation method thereof
12/05/2012CN102258535B Method for preparing veterinary compound iron dextran injection and influence of veterinary compound iron dextran injection on growth of mice
12/05/2012CN102215853B Phytocomplex from bergamot fruit, process of manufacture and use as dietary supplement and in the pharmaceutical field
12/05/2012CN102204942B Method for extracting corylus heterophylla leaf flavone
12/05/2012CN102151260B Andrographolide and berberine combination and application thereof
12/05/2012CN102139115B Preparation method for atorvastatin cyclodextrin inclusion compound and oral solid preparation thereof
12/05/2012CN102056609B Pharmaceutical combination
12/05/2012CN101966173B Medicinal use of dinitrobenzoylsilybin for preparing glycosidase inhibitor
12/05/2012CN101928213B Process for the preparation of a granular microbial biomass and isolation of valuable compounds therefrom
12/05/2012CN101851605B Selective medium of liver stem cells, method for selectively separating and amplifying liver stem cells, and medicinal composition for treating diabetes
12/05/2012CN101684090B Method for preparing amorphous atorvastatin calcium
12/05/2012CN101610790B Novel compositions and uses thereof
12/05/2012CN101565404B Heterocyclic compounds
12/05/2012CN101559059B Pharmaceutical composition containing amiloride hydrochloride and preparation method thereof
12/05/2012CN101541780B Fibrate carboxylate compounds, preparation methods and uses thereof
12/05/2012CN101397294B N-substituted pyrrolidine derivates and uses thereof
12/05/2012CN101330919B Pharmaceutical composition including (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrim idin-5-yl]-(3R, 5S)-3,5-dihydroxyhept-6-enoic acid
12/05/2012CN101212911B Infant nutrition with hydrolised proteins
12/04/2012US8324386 Somatostatin-dopamine chimeric analogs
12/04/2012US8324383 Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
12/04/2012US8324242 Modulators of ATP-binding cassette transporters
12/04/2012US8324241 Triazolo compounds useful as DGAT1 inhibitors
12/04/2012US8324214 1,3-dihydro-2H-pyrrolo[3,2-bpyridin-2-one derivatives, preparation thereof and therapeutic uses thereof
12/04/2012US8324176 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
12/04/2012US8323648 Methods of modulating and identifying agents that modulate intracellular calcium
12/04/2012CA2617363C Use of ivabradine for the manufacture of medications for the treatment of endothelial dysfunction
12/04/2012CA2600203C New salt and polymorphs of a dpp-iv inhibitor
12/04/2012CA2589252C Ameliorant for renal insufficiency
12/04/2012CA2573479C Effective use method of medicaments and method of preventing expression of side effect
12/04/2012CA2557269C Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
12/04/2012CA2548323C Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions
12/04/2012CA2463879C Glycoprotein compositions
12/04/2012CA2422294C Modulation of il-2- and il-15-mediated t cell responses
11/2012
11/29/2012WO2012162542A1 Amylin peptides and derivatives and uses thereof
11/29/2012WO2012162409A1 Biphenyl derivatives useful as glucagon receptor antagonists
11/29/2012WO2012162394A2 Compositions and methods for treating renal disease
11/29/2012WO2012162108A2 Boron-containing compositions and methods therefor
11/29/2012WO2012161670A2 Method for treating diabetes and other glucose regulation disorders using stem cells
11/29/2012WO2012161622A2 Incretin hormone secretion stimulators, method for producing and using same
11/29/2012WO2012161518A2 Novel thiourea derivatives as activators of rorα and pharmaceutical composition containing same
11/29/2012WO2012161119A1 Novel spiropiperidine derivative and pharmaceutical product containing same
11/29/2012WO2012160218A1 Family of aryl, heteroaryl, o-aryl and o-heteroaryl carbasugars
11/29/2012WO2012159446A1 METHOD FOR PRODUCING NATURAL β-CAROTENE BY FERMENTATION AND USE THEREOF
11/29/2012WO2012159215A1 Compositions and methods for efficacious and safe delivery of sirna using specific chitosan-based nanocomplexes
11/29/2012WO2012138147A3 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof
11/29/2012WO2012129513A3 Blockage of pai-1 in diabetic cd34+ stem cells corrects cellular dysfunction
11/29/2012WO2012098562A3 Liquid oral compositions of lanthanum salts
11/29/2012US20120302794 Derivatives of venlafaxine and methods of preparing and using the same
11/29/2012US20120302641 Biphenyl derivatives useful as glucagon receptor antagonists
11/29/2012US20120302636 Method of treating a disorder associated with mtp
11/29/2012US20120302631 Inhibitors of PFKFB3 for Cancer Therapy
11/29/2012US20120302610 Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonists
11/29/2012US20120302609 Pyrazolines for the Modulation of PKM2
11/29/2012US20120302607 C4-substituted alpha-keto oxazoles
11/29/2012US20120302602 Vanilloid Receptor Ligand Compounds, Pharmaceutical Compositions Containing Them, a Method of Producing Them and the Use Thereof to Treat Pain and Various Other Conditions
11/29/2012US20120302591 Methods of using 8-carboxamido-2,6-methano-3-benzazocines
11/29/2012US20120302589 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
11/29/2012US20120302585 Inhibitors of fatty acid uptake and methods of use
11/29/2012US20120302584 Novel salts forms of pyrimidin-5-yl acetic acid derivative
11/29/2012US20120302583 New Compounds I
11/29/2012US20120302578 Aminooxazole Inhibitors of Cyclin Dependent Kinases
11/29/2012US20120302576 Ampk modulators
11/29/2012US20120302566 Indanyloxydihydrobenzofuranylacetic acids
11/29/2012US20120302564 (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases
11/29/2012US20120302561 Compounds, Formulations, and Methods of Protein Kinase C Inhibition
11/29/2012US20120302549 Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
11/29/2012US20120302547 Novel mch receptor antagonists
11/29/2012US20120302544 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
11/29/2012US20120302539 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/29/2012US20120302537 Treatment methods using pharmaceutical solid state forms
11/29/2012US20120302536 Use of DHEA Derivatives for Enhancing Physical Performance
11/29/2012US20120302521 Inhibition of pancreatic lipase
11/29/2012US20120302513 Mitochondrial Function Improver
11/29/2012US20120302505 Cyclodextrin-based polymers for therapeutic delivery
11/29/2012US20120302502 Mucosal delivery compositions comprising a peptide complexed with a crown compound and/or a counter ion
11/29/2012US20120302498 Insulin like peptides
11/29/2012US20120302497 Methods of treating medical conditions using calcitonin analogs
11/29/2012US20120301561 Effects of dichrostachys glomerata on various cardiovascualr risk factors and metabolic syndrome
11/29/2012US20120301559 Dietary regimens useful for mimicking caloric restrictions
11/29/2012US20120301552 CaSR Antagonist
11/29/2012US20120301545 Calcium carbonate granulation
11/29/2012US20120301535 Combination peptide-nanoparticles and delivery systems incorporating same
11/29/2012US20120301520 Directly compressible magnesium hydroxide carbonate
11/29/2012US20120301519 Calcium carbonate granulation
11/29/2012US20120301513 Composition comprising solanum glaucophyllum for preventing and/or treating hypocalcaemia and for stabilizing blood calcium levels
11/29/2012US20120301485 Juvenile Hemochromatosis Gene (HFE2A) Cleavage Products and Uses Thereof
11/29/2012US20120301472 Reagents and treatment methods for autoimmune diseases
11/29/2012US20120301451 Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
11/29/2012US20120301450 Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism
11/29/2012CA2837088A1 Biphenyl derivatives useful as glucagon receptor antagonists
11/29/2012CA2835755A1 Family of aryl, heteroaryl, o-aryl and o-heteroaryl carbasugars
11/29/2012CA2835147A1 Compositions and methods for efficacious and safe delivery of sirna using specific chitosan-based nanocomplexes
1 ... 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 ... 1298